Trader J's Inner Circle Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Trader J's Inner Circle

NVDA 188.23

+0.1%

Nov 7 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LTK007 who wrote (27799)	3/4/2000 4:17:00 PM
From: Softechie	Read Replies (1) of 56532

Max I'm retiring with AVNR. I have accumulated closer to 400K shares of this company. This should keep me busy for a very long time. CEO have been doing road shows with Reddington for last couple weeks and next week they have 3 more to do. Deal with Smithklein and Beecham is imminent in 2 weeks. This includes up front payment in millions of dollars. Moving from OTCBB hell to AMEX or NASDAQ depending on share price. They have enough cash in the bank for qualification but share price is holding it back. AMEX requires $3 and NASDAQ $4 for Small Cap. FDA to come back with Marketing Approval. Deadline date is 6/3. ALS and Anti-IgE drugs are in the pipeline. Some predict buyout from a major pharma at $6 but who knows. Here's another hint for you: Check around and see if you can find any biotech stocks that have got FDA Approvable status for OTC drug and still under $5 and let me know. ARNX don't even have NDA (New Drug Application) filed for their cancer cure drug. Don't let the hype got you. I guess it's (hype) relative when comparing with internet stocks. I'm taking Warren Buffett advice of investing in company you know best and I know Avanir good.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next